• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM

IMMUTEP LIMITED - Charts / Financials

1.89% ! 27.0¢
Market Cap $396.3M  !

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.59pm 31/07/2025 (20 minute delay) ?
Day
Open 26.5¢   Day High 27.0¢   Day Low 26.5¢
Daily Volume 690429
Bids   Sellers
Number Price Volume   Number Price Volume
3 26.5¢ 92193   7 27.5¢ 134673

Directors & Senior Management

Mr. Marc Voigt Chief Executive Officer, Executive Director
Ms. Deanne Miller Chief Operating Officer, General Counsel, Joint Company Secretary
Dr. Frederic Triebel Chief Scientific Officer, Executive Director
Dr. Stephan Winckels Interim Chief Medical Officer
Ms. Indira Naidu Joint Company Secretary
Dr. Russell John Howard Independent Non-Executive Chairman of the Board
Mr. Peter A. Meyers Independent Non-Executive Deputy Chairman of the Board
Ms. Lis Boyce Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
27.0¢
Change
0.005(1.89%)
Mkt cap ! $396.3M
Open High Low Value Volume
26.5¢ 27.0¢ 26.5¢ $185.3K 690.4K

Buyers (Bids)

No. Vol. Price($)
3 92193 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 134673 7
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
Last
27.0¢
  Change
0.005 ( 0.00 %)
Open High Low Volume
26.8¢ 27.0¢ 26.5¢ 586726
Last updated 15.59pm 31/07/2025 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.